UBXN2A and colorectal carcinoma: The achieved results support the following hypothesis: the induction of UBXN2A by VTD suppresses the overdriven mTORC2 pathway using in vitro and in vivo models, resulting in suppression of migration, invasion, and stemness of CRC cells as well as the induction of apoptosis.